“Michigan State University faculty member develops innovative technology to boost immune cells in cancer clusters”

2023-05-25 14:16:53

A faculty member at Michigan State University, Saudi Dr. Yasser Al-Damen, obtained a patent from the US Patent Office. An innovation isotope that stimulates the work of immune cells within cancer clusters and increases the effectiveness of vaccines.

Al-Damen said that the current patent describes the development of a modern technology that works to target an immune protein that is present at a high concentration on the surface of the cells of the immune system in chronic disease conditions, such as cancer, and when exposed to specific microbes, such as HIV, the malaria parasite, and bacteria that It causes tuberculosis and chronic diseases.

He added that the target protein in this project is called CRACC, and our research has proven that CRACC protein is present in high concentration on the surface of immune system cells in cancerous cases, and this protein is based on inhibiting the work of immune system cells, which helps the spread of cancer.

It is noteworthy that Al-Damen occupies, in addition to his duties, the position of Deputy Director of Research at the Faculty of Medicine at the university, and supervised students in the doctoral and master’s levels, as well as participating in 15 conferences worldwide, and membership in a number of advisory committees at the university working on developing research.